Hope Engelbrecht, MD
Hospice and Palliative Medicine · Round Rock, TXNPI 1407388531
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 11 manufacturers, the largest accounting for just 23.5% — the pattern of someone who eats at a lot of different presentations.
Across 16 payments — averaging $21.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bristol Myers Squibb$83
- Daiichi Sankyo Inc.$50
- Regeneron Healthcare Solutions, Inc.$41
- AbbVie$32
- AstraZeneca$27
- Gilead$26
- plus $93 from 5 others
What the payments were for
- Food & beverage$352100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bristol Myers Squibb | 4 | $83 |
| Daiichi Sankyo Inc. | 2 | $50 |
| Regeneron Healthcare Solutions, Inc. | 2 | $41 |
| AbbVie | 1 | $32 |
| AstraZeneca | 1 | $27 |
| Gilead | 1 | $26 |
| Johnson & Johnson | 1 | $23 |
| Sobi, Inc | 1 | $21 |
| Eisai Inc. | 1 | $17 |
| Genentech USA, Inc. | 1 | $17 |
| Tersera Therapeutics LLC | 1 | $16 |
How this compares
$352 in reported general payments places this provider in the 75th percentile of 136 hospice and palliative medicine providers in Texas.
See all hospice and palliative medicine providers in Texas →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fentanyl | 103 | $12,397 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 72 | $2,397 |
| Hydromorphone Hcl | 92 | $2,218 |
| Oxycodone Hcl | 91 | $1,635 |
| Morphine Sulfate ErMorphine Sulfate | 49 | $1,534 |
| Morphine Sulfate | 22 | $813 |
| Ondansetron OdtOndansetron | 29 | $556 |
| Megestrol Acetate | 12 | $498 |
| Gabapentin | 46 | $473 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 18 | $390 |
| Pregabalin | 35 | $365 |
| Mirtazapine | 21 | $358 |
| Celecoxib | 17 | $329 |
| Methadone Hcl | 22 | $284 |
| Duloxetine Hcl | 13 | $181 |
Paid to pharmacies, not to this prescriber.
Other hospice and palliative medicine in Round Rock
- Joseph ArthurHouston$19K
- Juan BecerraEl Paso$10K
- Ishwaria SubbiahHouston$10K
- Olutola AdetonaSan Antonio$7K
- Tri LuongDallas$4K
- Morvarid RezaieFort Worth$4K
- Debra GummeltShenandoah$2K
- Elizabeth BrownDallas$1K
- Stacey MuhammadWebster$1K
- Neeti KothareHouston$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.